We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01454804
Recruitment Status : Completed
First Posted : October 19, 2011
Last Update Posted : April 13, 2016
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2015
  Study Completion Date : March 2015